3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
181
Breast Neoplasms
154
Prostatic Neoplasms
144
Lung Neoplasms
139
Glioblastoma
119
Head and Neck Neoplasms
115
Squamous Cell Carcinoma of Head and Neck
110
Rectal Neoplasms
107
Lymphoma
101
Esophageal Neoplasms
100
Pancreatic Neoplasms
76
Esophageal Squamous Cell Carcinoma
71
Leukemia
70
Neoplasms
67
Brain Neoplasms
67
Lymphoma, Follicular
63
Precursor Cell Lymphoblastic Leukemia-Lymphoma
62
Lymphoma, Non-Hodgkin
62
Lymphoma, Large B-Cell, Diffuse
58
Hodgkin Disease
56
Uterine Cervical Neoplasms
53
Central Nervous System Neoplasms
53
Leukemia, Lymphocytic, Chronic, B-Cell
52
Gliosarcoma
51
Sarcoma
50
Colorectal Neoplasms
50
Neoplasm Metastasis
45
Lymphoma, Large-Cell, Immunoblastic
45
Glioma
44
Burkitt Lymphoma
43
Interventions
Temozolomide
2
lutetium Lu 177 dotatate
1
copper dotatate CU-64
1
Vincristine
1
Valproic Acid
1
Thiotepa
1
Sunitinib
1
Radiotherapy
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Maintenance Chemotherapy
1
Lutetium-177
1
Lutetium
1
Lomustine
1
Interleukin-12
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Erlotinib Hydrochloride
1
Cisplatin
1
Busulfan
1
Bone Marrow Transplantation
1
Aminolevulinic Acid
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neuroectodermal Tumors
×
Radiotherapy
×
Clear all
NCT01614132
2020-03-31
NOA-07
University of Regensburg
Phase 1/2
Completed
33 enrolled